Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert Van Manen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|January 12, 2013
Tigecycline-related pancreatitis: a review of spontaneous adverse event reportsEmmanuel Okon, Christian Engell, Robbert van Manen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 13, 2024
Antineoplastic agents associated with neutropenic enterocolitis in patients with malignancy: A quantitative safety signal analysisAli Amanati, Robbert Van Manen, Sarvin Sajedianfard, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2025
Exploring the potential relationship between antineoplastic agents and their association with stomatitis and oral candidiasis in cancer patientsAli Amanati, Robbert Van Manen, Laleh Mahmoudi, et al.
Drug Safety|June 23, 2022
Signaling COVID-19 Vaccine Adverse EventsRave Harpaz, William DuMouchel, Robbert Van Manen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|January 12, 2013
Tigecycline-related pancreatitis: a review of spontaneous adverse event reportsEmmanuel Okon, Christian Engell, Robbert van Manen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 13, 2024
Antineoplastic agents associated with neutropenic enterocolitis in patients with malignancy: A quantitative safety signal analysisAli Amanati, Robbert Van Manen, Sarvin Sajedianfard, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2025
Exploring the potential relationship between antineoplastic agents and their association with stomatitis and oral candidiasis in cancer patientsAli Amanati, Robbert Van Manen, Laleh Mahmoudi, et al.
Drug Safety|June 23, 2022
Signaling COVID-19 Vaccine Adverse EventsRave Harpaz, William DuMouchel, Robbert Van Manen, et al.
Pageof 1